Clinical trial: multicentral preventive antibiotics with cystectomy within enhanced recovery after surgery (MACS)
Vol. 69 No. 3 (2023), ORIGINAL ARTICLES. A. PROTOCOLS OF CLINICAL RESEARCH
Vol. 69 No. 3 (2023)

Clinical trial: multicentral preventive antibiotics with cystectomy within enhanced recovery after surgery (MACS)

ORIGINAL ARTICLES. A. PROTOCOLS OF CLINICAL RESEARCH
https://doi.org/10.37469/0507-3758-2023-69-3-415-421
Published 30.06.2023
Maria Berkut
FSBI “N.N. Petrov NMRC of oncology” Ministry of Healthcare of Russian Federation
https://orcid.org/0000-0002-6276-1716
Eldar Mamizhev
ФГБУ «НМИЦ онкологии им. Н.Н Петрова» Минздрава России
https://orcid.org/0000-0001-6883-777X
Tatyana Galunova
FSBI “N.N. Petrov NMRC of oncology” Ministry of Healthcare of Russian Federation
https://orcid.org/0000-0002-4588-6496
Alexey Novik
FSBI “N.N. Petrov NMRC of oncology” Ministry of Healthcare of Russian Federation
https://orcid.org/0000-0002-2430-4709
Daria Rumyantseva
FSBI “N.N. Petrov NMRC of oncology” Ministry of Healthcare of Russian Federation
https://orcid.org/0000-0002-8067-9150
Alexander Nosov
FSBI “N.N. Petrov NMRC of oncology” Ministry of Healthcare of Russian Federation
https://orcid.org/0000-0003-3850-7109
pdf (Русский)

Keywords

bladder cancer
antibiotic prophylaxis
cystectomy
urinary diversion
carbapenemase
ERAS protocol

How to Cite

Berkut, M., Mamizhev, E., Galunova, T., Novik , A., Rumyantseva , D., & Nosov, A. (2023). Clinical trial: multicentral preventive antibiotics with cystectomy within enhanced recovery after surgery (MACS). Voprosy Onkologii, 69(3), 415–421. https://doi.org/10.37469/0507-3758-2023-69-3-415-421
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Abstract

Introduction. Bladder cancer (BC) ranks 10th in the structure of oncological morbidity, 573.000 incidence and 213.000 mortality cases are registered annually [1]. In 25-30% cases of BC are detected initially with muscular layer invasion, where the gold standard of treatment is radical cystectomy (RC). RC is associated with a high level of perioperative and long-term complications [2].

Aim. To study the incidence of infectious complications after RC with early postoperative patient recovery (ERAS) protocol during 30-90 days after surgery.

https://doi.org/10.37469/0507-3758-2023-69-3-415-421
pdf (Русский)

References

Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):20949. doi:10.3322/caac.21660.

Hautmann RE, de Petriconi RC, Volkmer BG. Lessons learned from 1,000 neobladders: the 90-day complication rate. J Urol. 2010;184(3):9904; quiz 1235. doi:10.1016/j.juro.2010.05.037.

Даренков С.П., Кривобородов Г.Г., Котов С.В. Осложнения радикальной цистэктомии с орто- и гетеротопической кишечной пластикой (обзор литературы). Вестник РГМУ. 2013;(4):49–53 [Darenkov SP, Krivoborodov GG, Kotov SV. Complications of radical cystectomy with ortho- and heterotopic intestinal plastic (literature review). Vestnik RSMU. 2013;(4):49–53 (In Russ.)].

Lawrentschuk N, Colombo R, Hakenberg OW, et al. Prevention and management of complications following radical cystectomy for bladder cancer. Eur Urol. 2010;57(6):9831001. doi:10.1016/j.eururo.2010.02.024.

Носов А.К., Рева С.А., Джалилов И.Б., Петров С.Б. Радикальная цистэктомия при раке мочевого пузыря: сравнение ранних хирургических осложнений при лапароскопической, открытой и видеоассистированyой операции. Онкоурология. 2015;11(3):71–78 [Nosov AK, Reva SA, Dzhalilov IB, Petrov SB. Radical cystectomy for bladder cancer: сomparison of early surgical complications during laparoscopic, open-access, and video-assisted surgery. Oncourology. 2015;11(3):71–78 (In Russ.)]. doi:10.17650/1726-9776-2015-11-3-71-78.

Clark JY, Raman JD. Urinary tract infection after radical cystectomy: a vexing problem despite prophylactic antibiotics. Transl Androl Urol. 2019;8(S5):S510–3. doi:10.21037/tau.2019.07.07.

Clifford TG, Katebian B, Van Horn CM, et al. Urinary tract infections following radical cystectomy and urinary diversion: a review of 1133 patients. World J Urol. 2018;36(5):775781. doi:10.1007/s00345-018-2181-2.

Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1999;20(4):25078; quiz 279-80. doi:10.1086/501620.

van Hemelrijck M, Thorstenson A, Smith P, et al. Risk of in-hospital complications after radical cystectomy for urinary bladder carcinoma: population-based follow-up study of 7608 patients. BJU Int. 2013;112(8):111320. doi:10.1111/bju.12239.

Witjes JA, Bruins HM, Cathomas R, et al. European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines. Eur Urol. 2021;79(1):82104. doi:10.1016/j.eururo.2020.03.055.

Атдуев В.А., Гасраталиев В.Э., Ледяев Д.С., и др. Предикторы послеоперационных осложнений радикальной цистэктоми. Онкология, Журнал им. П.А. Герцена. 2019;8v (5):348–357 [Atduev VA, Gasrataliev VE, Ledyaev DS, et al. Predictors for postoperative complications from radical cystectomy. Oncology, Journal im. P.A. Herzen. 2019;8(5):348–57 (In Russ.)]. doi:10.17116/onkolog20198051348.

Профилактика инфекций области хирургического вмешательства/ Клинические рекомендации под редакцией Брико Н.И., Божкова С.А., Брусина Е.Б., Жедаева М.В., Зубарева Н.А., Зуева Л.П., и [др.]. Н. Новгород: Изд-во «Ремедиум Приволжье», 2018:72 [Prevention of infections in the surgical field. Clinical guidelines edited by Brico NI, Bozhkova SA, Brusina EB, Zhedaeva MV, Zubareva NA, Zueva LP, et al. Nizhny Novgorod: Remedium Privolzhie; 2018:72 (In Russ.)].

Котов С.В., Хачатрян А.Л., Котова Д.П., и др. Анализ результатов применения протокола eras в реальной клинической практике при радикальной цистэктомии (первое проспективное мультицентровое исследование в России). Урология. 2019;30(6):60–6 [Kotov SV, Khachatryan AL, Kotova DP, et al. Analysis of the results of ERAS protocol in real-life clinical practice after radical cystectomy (the first prospective multicenter study in Russia). Urologiia. 2019;30(6):60–6 (In Russ.)]. doi:10.18565/urology.2019.6.60-66.

Котов С.В., Хачатрян А.Л., Гуспанов Р.И., и др. Компаративный анализ применения протокола ускоренного восстановления (ERAS) при радикальной цистэктомии. Экспериментальная и клиническая урология. 2020;12(2):78–83 [Kotov SV, Khachatryan AL, Guspanov RI, et al. Comparative analysis of the usage ERAS protocol after radical cystectomy. Experimental and Сlinical Urology, 2020;12(2):78–83 (In Russ.)]. doi:10.29188/2222-8543-2020-12-2-78-83.

Peerbocus M, Wang ZJ. Enhanced recovery after surgery and radical cystectomy: a systematic review and meta-analysis. Res Rep Urol. 2021;13:535547. doi:10.2147/RRU.S307385.

Designing clinical research: an epidemiologic approach. 4th edition. Hulley SB, Cummings SR, Browner WS, Grady D, Newman TB. Lippincott Williams & Wilkins, Philadelphia, 2013;75.

Fleiss JL, Tytun A, Ury HK. A simple approximation for calculating sample sizes for comparing independent proportions. Biometrics. 1980;36(2):3436.

Timsit JF, de Kraker MEA, Sommer H, et al. Appropriate endpoints for evaluation of new antibiotic therapies for severe infections: a perspective from COMBACTE's STAT-Net. Intensive Care Med. 2017;43(7):10021012. doi:10.1007/s00134-017-4802-4.

Недогода С.В., Петров В.И. Рандомизированные контролируемые клинические исследования (продолжение). Справочник поликлинического врача. 2011;(2):4–9 [Nedogoda SV, Petrov VI. Randomized controlled clinical trials (continued). Handbook of a polyclinic doctor. 2011;(2):4–9 (In Russ.)].

Каприн А. Д., Старинский В. В., Шахзадова А.О. Состояние онкологической помощи населению России в 2021 году. Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. М.: МНИОИ им. П.А. Герцена − филиал ФГБУ «НМИЦ радиологии» Минздрава России. 2022:239 [Kaprin AD, Starinsky VV, Shakhzadova AO. The state of oncological care for the population of Russia in 2021. Ed. by AD Kaprina, VV Starinsky, AO Shakhzadova. M.: MSROI P.A. Gertsen, FSBI «NMRC of Radiology» MH of Russia. 2022:239 (In Russ.)].

Ross JPJ, Breau RH, Vigil H, et al. Association between radical cystectomy prophylactic antimicrobial regimen and postoperative infection. Can Urol Assoc J. 2021;15(12):64451. doi:10.5489/cuaj.7158.

Беляев А.М., Белоусова Т.А., Раскин Г.А., Галунова Т.Ю. Прогностические факторы и ранняя диагностика послеоперационных инфекционных осложнений у больных колоректальным раком. Medline.ru. Российский биомедицинский журнал. 2013;(14):440–454 [Belyaev AM, Belousova TA, Raskin GA, Galunova TYu. Prognostic factors and early diagnosis of postoperative infectious complications in patients with colorectal cancer. Medline.ru. Russian Biomedical Journal. 2013;(14):440–454 (In Russ.)].

Altobelli E, Buscarini M, Gill HS, et al. Readmission rate and causes at 90-day after radical cystectomy in patients on early recovery after surgery protocol. Bladder Cancer. 2017;3(1):5156. doi:10.3233/BLC-160061.

Тапальский Д.В., Осипов В.А., Жаворонок С.В. Карбапенемазы грамотрицательных бактерий: распространение и методы детекции. Медицинский журнал. 2012;(2):10–5 [Tapalsky DV, Osipov VA. Carbapenemases of gram-negative pathogens: spread and methods of detection. Medical journal. 2012;(2):10–5 (In Russ.)].

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

© АННМО «Вопросы онкологии», Copyright (c) 2023

Most read articles by the same author(s)